GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moleculin Biotech Inc (LTS:0K2H) » Definitions » Accumulated other comprehensive income (loss)

Moleculin Biotech (LTS:0K2H) Accumulated other comprehensive income (loss) : $-0.04 Mil (As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Moleculin Biotech Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Moleculin Biotech's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2025 was $-0.04 Mil.

Moleculin Biotech's quarterly Accumulated other comprehensive income (loss) declined from Sep. 2024 ($0.00 Mil) to Dec. 2024 ($-0.04 Mil) but then increased from Dec. 2024 ($-0.04 Mil) to Mar. 2025 ($-0.04 Mil).

Moleculin Biotech's annual Accumulated other comprehensive income (loss) declined from Dec. 2022 ($0.01 Mil) to Dec. 2023 ($-0.01 Mil) and declined from Dec. 2023 ($-0.01 Mil) to Dec. 2024 ($-0.04 Mil).

Moleculin Biotech Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Moleculin Biotech's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moleculin Biotech Accumulated other comprehensive income (loss) Chart

Moleculin Biotech Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.04 0.01 -0.01 -0.04

Moleculin Biotech Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.01 - -0.04 -0.04

Moleculin Biotech Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Moleculin Biotech Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Moleculin Biotech's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Moleculin Biotech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moleculin Biotech Inc (LTS:0K2H) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
UBX BIXT IBIO ICU SYBX ZEOX RLYB INAB NKGN EDSA VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
MBRX:USA
Address
5300 Memorial Drive, Suite 950, Houston, TX, USA, 77007
Website
https://www.moleculin.com
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Moleculin Biotech Headlines

No Headlines